Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.310
-0.081 (-5.82%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $13.33 million as of April 23, 2025. Its market cap has decreased by -16.18% in one year.
Market Cap
13.33M
Enterprise Value
6.33M
1-Year Change
-16.18%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $13.33M, a decrease of -88.44%. That is a compound annual growth rate of -26.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 14.40M | -30.10% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.66B |
| UnitedHealth Group | 393.42B |
| Johnson & Johnson | 376.61B |
| AbbVie | 299.22B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 223.57B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |